SoKor’s IPO rallies on SK Bioscience’s impressive share debut

18.03.2021 - Davydova Maria
SoKor’s IPO rallies on SK Bioscience’s impressive share debut

South Korean firm SK Bioscience Co Ltd made an impressive trading debut, with its shares recording a 30% increase on Thursday. This was mainly from investors’ optimism that the biopharmaceutical company would provide interesting breakthroughs, turning its value to more than $12 billion.

The jump, which was the biggest in nearly four years, came to be the best opening performance under the KOSPI. Data from Korea Exchange showed that the vaccine developer raised 1.5 trillion won in the country’s largest initial public offering. The figure placed just below the 2.7 trillion won recorded by mobile game developer Netmarble in 2017.

According to analysts, SK Bioscience’s strong listing contributed to the country’s busy IPO market this year. With investors’ upbeat demand, more listings by companies that profit from health concerns and stay-at-home habits could be expected.

Risk disclaimer "PROMETHEUS LTD – Trust Company Complex, Ajeltake Road, Ajeltake Island, Majuro, Republic of the Marshall Islands MH96960 is a financial services institution outside the European Union Area, which is subject to the supervision of the IFMRRC Certificate 0395 AA V0155 Trading in Forex/ CFDs and Other Derivatives is highly speculative and carries a high level of risk. It is possible to lose all your capital. 70% of trading deals can be unprofitable. These products may not be suitable for everyone and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. This Website may contain information in particular regarding financial services and products that could be regarded b a E.U. supervisory authority as an offer of financial services targeted in Europe. ESMA intervention measures do not apply to customers of PROMETHEUS LTD and it is your responsibility to choose a company which is most suitable for your trading needs. By clicking continue you confirm that you have read, understood and agree to the risk disclosures, terms of service, cash policies, privacy policies and this notice and that you are visiting this website on your own initiative, without any encouragement whatsoever from or PROMETHEUS LTD." Cookies notification: We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we assume that you are happy with it. Read more. Continue

Help with deposit?